Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061203) titled 'Follitropin Beta vs Follitropin Delta for Poor Responders to Rekovelle: A P... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061202) titled 'Study on the Effects of Vocal Music Education on the Mental Well-being of W... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061199) titled 'A study investigating the clinical course of bronchiectasis after treatment... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061198) titled 'Development and usability study of a decision-making aid for men considerin... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061197) titled 'Long-term outcomes of half-dose photodynamic therapy for chronic central se... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061196) titled 'rTMS and CBT Combination Therapy for Difficult-to-Treat Depression: A Rando... Read More
Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061193) titled 'Ultra-early steroid tape intervention for preventing hypertrophic scars aft... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More